ClinicalTrials.Veeva

Menu

Study of Platelet Population Changes Under Circulatory Support With ECMO (ECMO-POP)

U

University Hospital, Strasbourg, France

Status

Enrolling

Conditions

Cardiac Failure
Respiratory Failure

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Advances in flow cytometry techniques have led to a better understanding of platelet phenotypes and have revealed the existence of four major platelet populations with distinct functional properties (native, proaggregating, procoagulating, or apoptotic). These phenotypes have a significant impact on the hemostatic capacity of blood platelets, and a proportional change in these populations during ECMO treatment could, at least in part, contribute to the observed complications.

Enrollment

75 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patient (≥18 years) treated in one of the intensive care units of the Anesthesia and Intensive Care Department at Strasbourg University Hospital.
  • Implanted with veno-arterial or veno-venous ECMO within the previous 24 hours.

Exclusion criteria

  • Subject who has expressed their opposition to participating in the study.
  • Subject under legal protection.
  • Subject under guardianship or curatorship.

Trial contacts and locations

1

Loading...

Central trial contact

Charles TACQUARD, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems